Trials
1 active
2 in total
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “MTBVAC is a novel TB vaccine candidate based on an attenuated M. tuberculosis clinical isolate of the Euro-American lineage. Attenuation is based on two independent, stable genetic deletions of the genes phoP and fadD26 coding for two major virulence factors, the transcription factor PhoP and the cell-wall lipids PDIM, respectively. We hypothesize that MTBVAC will provide improved protection, as…”In the company’s words, NCT04975178 on ClinicalTrials.gov
- Tested for
- Tuberculosis
- Main trialPhase 3
- “The objective of this project is to demonstrate safety, immunogenicity and improved efficacy of the new live attenuated M. tuberculosis vaccine called MTBVAC in a Phase 3 efficacy trial in HIV-uninfected infants born to HIV-infected and HIV-uninfected mothers as compared to standard of care BCG vaccination. The proposal builds upon a group of TB vaccine development partners in Europe and sub-Saharan Africa established in a previous EDCTP-supported project. It creates an expanded consortium of clinical trial partners for the optimal implementation of a large infant efficacy trial of MTBVAC in…”In the company’s words, NCT04975178 on ClinicalTrials.gov
Other drugs for Tuberculosis
- QuabodepistatOtsuka · Phase 3
- SudapyridineShanghai Jiatan Pharmatech Co., Ltd · Phase 3
- RBCG-N-RSVBiothervax SpA · Phase 2
- BNT164a1BioNTech · Phase 1/2
- BNT164b1BioNTech · Phase 1/2
- JDB0131WestVac Biopharma Co., Ltd. · Phase 2
Coming up1
- Feb 2029Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | Feb 2029 | Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa | |
| Phase 2Completed | 17 May 2022 | Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026